Reading this now, it gives a better understanding of why

New Post Public Reply Private Reply Replies (0) Message Board
Almost A Myth
1,052
Reading this now, it gives a better understanding of why the Agrimed situation set us so far back. It almost sounds like the Wellness Teladoc networks were originally supposed to run through Agrimed.

I have misinterpreted this kind of information before, so take it fwiw. Maybe he was talking about the products? IDK. I thought it was a possible reference to what we might perceive as a new development with Teladoc, but was alluded to almost a year ago.

https://microcapdaily.com/stock-spotlight-is-...vc/124431/

Quote:
Stock Spotlight is UNIVEC, Inc. (OTCMKTS: UNVC) 0
BY CARRIE RIVERS ON MAY 28, 2019MEDIA & TECHNOLOGY, MICRO CAP INSIDER, SMALL CAPS
UNIVEC, Inc. (OTCMKTS: UNVC) continues to move higher in recent days topping $0.02 per share, a long way up from where it started last year in triple zero land. We mentioned the stock when it was $0.0076

UNVC is led by Dr David Dalton; the International Forum on Advancements in Healthcare (IFAH) has named Dr. David Dalton as one of the “Top 100 Healthcare Leaders” for 2019. The award will be presented in June.

International Forum on Advancements in Healthcare – IFAH (formerly Smart Health Conference) will bring together healthcare professionals at Caesars Palace, Las Vegas on June 18-20. Participants include startups, hospitals, manufacturers, technology providers, insurers as well as government agencies.

In recognition of his public service, Dr. Dalton has received a Medal of Freedom and an award from the Black Caucus of State Legislators. The Black CEO Hall Of Fame inducted Dalton in 2006 and his hometown in Grafton, West Virginia, has also honored him. He was inducted into the Taylor County School’s Hall of Fame in 2013 and inducted into the West Virginia School of Pharmacy Centennial Hall of Fame in 2014.

UNIVEC, Inc. (OTCMKTS: UNVC) is a Specialty Pharmaceutical Company with a couple of exciting projects in the pipeline. The Company is led by mover and shaker; Dr. Dalton,e an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom.

Last year Univec entered into a partnership with Agrimed to manufacture and distribute its medical cannabis transdermal patch for treatment and relief of approved medical conditions. A transdermal patch adheres or sticks to the skin and delivers a specific dose of medication through the skin and into the bloodstream.

Agrimed is a Delaware Company developing, producing and selling products derived from cannabis. Agrimed owns one of the twelve licenses authorized by the Commonwealth of Pennsylvania to grow and process medical cannabis. Agrimed has teamed up with Former Pittsburgh Steelers great Jack Ham, a native of Johnstown, to promote the use of medical marijuana in Pennsylvania.


Dr. David Dalton, Univec’s CEO said “Combining Univec’s medical and pharmaceutical expertise with AGRiMED Industries’ innovative approach to the cannabis marketplace and commitment to its patient focused services makes for a very powerful partnership to expand the treatment options available to the medical community.”

On October 20, Agrimed announced the election of Dr. David Dalton to their Board of Directors, effective immediately. In addition to over 45 years’ experience in the pharmaceutical world, Dr. Dalton served over 18 years as Vice President of Rite Aid, a chain of retail drug stores, and then founded and served as Chairman, President, CEO of several successful pharmaceutical and pharmaceutical related companies: Mednet, ManagedcareRx, Sivault Systems. Dr. Dalton is presently Chairman, President, CEO of Wellness Teladoc, Pharmacy Services Inc, Health Resources Inc and Univec Inc (UNVC). Dr. Dalton is an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom.

Univec CEO Dr. David Dalton recently posted on linkedin “Univec Transdermal CBD Patch will have patient assistance programs including no cost.” CBD stocks are on fire right now since reported surfaced that Coca-Cola is monitoring the nascent industry and is interested in drinks infused with CBD. With a rising number of various CBD products available in mainstream markets, consumers are spending more on CBD products than ever before. The Brightfield Group estimates the space will top $22 billion within the next 4 years, making it one of the more enticing spaces from an opportunity standpoint.

Currently trading at a $23 million market valuation according to OTCMarketsgroup it looks as if there is a lot going on behind the scenes at Univec. At the end of last year CEO Dr. Dalton has been very active getting elected to the board of Agrimed. He has also posted on Linkedin recent posting “Univec Transdermal CBD Patch will have patient assistance programs including no cost.” We will be updating on UNVC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with UNVC.

Disclosure: we hold no position in UNVC either long or short and we have not been compensated for this article.

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials










Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Fangzhou Achieves National High-Tech Status Amid Innovation Surge

Updated Category News Views 417

Fangzhou Recognized as a 2024 National High-Tech Enterprise Beijing Fangyixing Information Technology Co., Ltd. has received the prestigious National High-Tech Enterprise certification for 2024. This endorsement highlights its innovative strides within the AI-driven healthcare sector. The recognition, awarded by key governmental bodies, is a testament to Fangyixing's...

Continue Reading
Ardagh Group Announces Departure of CFO John Sheehan

Updated Category News Views 168

Ardagh Group Announces Transition in Leadership In a significant development for Ardagh Group S.A., John Sheehan will step down from his position as Group CFO as the year concludes. This announcement came after discussions with the Board earlier in the year, marking a planned transition as the company prepares for future opportunities. Gratitude for Contributions Mark...

Continue Reading
Massive Viewership for Sean Hannity's Trump Musk Interview

Updated Category News Views 409

Sean Hannity's Stunning Interview Achieves Record Viewership During a significant television event, Sean Hannity's exclusive interview with President Donald Trump and Elon Musk drew an impressive audience of 5.4 million viewers. This remarkable session not only outperformed competing shows in its time slot but also represented a significant increase in engagement compared...

Continue Reading
Ourself Launches Innovative Serum to Brighten Complexion

Updated Category News Views 297

Introducing the Complexion Brightening Serum Ourself has made significant strides in skincare innovation with the launch of its new Complexion Brightening Serum, designed specifically to combat skin discoloration. This innovative product is clinically proven to visibly reduce discoloration and plays a vital role in preventing future pigment formation, marking a major leap...

Continue Reading
ISS A/S Steps Up with Share Buyback Initiative in 2025

Updated Category News Views 182

ISS A/S Unveils Share Buyback Program to Enhance Shareholder Value In an exciting development for investors, ISS A/S, a prominent player in the workplace experience and facility management sector, has initiated a share buyback program aimed at redistributing excess cash to its shareholders. The announcement came on a notable date earlier in the year, marking a strategic...

Continue Reading